Cite
HARVARD Citation
Omori, K. et al. (2018). Lipocalin‐type prostaglandin D synthase‐derived PGD2 attenuates malignant properties of tumor endothelial cells. Journal of pathology. 244 (1), pp. 84-96. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Omori, K. et al. (2018). Lipocalin‐type prostaglandin D synthase‐derived PGD2 attenuates malignant properties of tumor endothelial cells. Journal of pathology. 244 (1), pp. 84-96. [Online].